Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

Half year trading update

3 Aug 2015 07:00

RNS Number : 8042U
Toumaz Limited
03 August 2015
 



3 August 2015

 

Toumaz Limited

 

Half year trading update

 

Toumaz Limited (AIM: TMZ, 'Toumaz', or the 'Group'), a pioneer in low-power, wireless semiconductor technologies for digital audio and healthcare, provides the following trading update for the six months ended 30 June 2015. 

 

Financial highlights

 

· Revenues up 30% at £14.0m (H1 2014: £10.8m)

· Gross profit up 40% to £6.3m (H1 2014: £4.5m)

· EBITDA loss £5.5m (H1 2014: loss £5.6m)

· R&D expenditure: £6.4m (H1 2014: £5.1m)

· As at 30 June 2015, the cash balance was £5.5m (31 December 2015: £12.5 million)

 

Overview

 

The Digital Audio division has performed strongly with revenues up 34% at £13.8m (£10.3m in H1 2014). Growth has been driven by the international expansion of digital radio and the rapid emergence of the connected audio market. Toumaz is well-positioned in both sectors and the recent co-development agreement with Google is a strong endorsement of the Group's forthcoming next generation connected audio solution.

 

In Healthcare, the commercial delivery of SensiumVitals® remains slow with revenues of £0.2m (£0.5m in H1 2014); but based on recent trials the Board remains confident that the fundamental economic and clinical value of the system will be demonstrated.

 

Anthony Sethill, CEO of Toumaz, commented:

 

"We are delighted with the growth of our Digital Audio business. Our co-development agreement with Google will be an important factor in further developing our position in connected audio.

 

"We are trialling SensiumVitals® in a number of hospitals, including the Queen Elizabeth Hospital Birmingham and St James's Hospital, Leeds. However, these complex systems for the healthcare environment need considerable amounts of data and trialling, which have delayed our commercial roll out.

 

"Overall, given the strong performance by Digital Audio, we remain on course to continue to grow the business in the second half of the year."

 

Enquiries:

 

Toumaz Limited

+44 (0)20 7391 0630

Anthony Sethill, Chief Executive Officer

Jonathan Apps, Chief Financial Officer

Peel Hunt LLP (Nominated Adviser and Broker)

+44 (0)20 7418 8900

Richard Kauffer/Euan Brown

Instinctif Partners

+44 (0)20 7457 2020

Adrian Duffield/Chantal Woolcock

 

About Toumaz (www.toumaz.com)

 

Toumaz Limited is a pioneer in low-power, wireless semiconductor and software technologies for healthcare and digital audio. The company has two divisions, Sensium Healthcare and Frontier Silicon. Sensium Healthcare develops wireless solutions for patient monitoring. Frontier Silicon provides chips, modules and software for digital radio and connected audio devices.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFSRDAILVIE
Date   Source Headline
26th Jun 20077:00 amPRNFinal Results
29th May 20077:00 amPRNProduct Collaboration
3rd May 20077:00 amPRNFuture Waves Design Win
20th Apr 20074:48 pmRNSHolding(s) in Company
23rd Mar 20075:04 pmRNSHolding(s) in Company
14th Mar 20074:36 pmRNSExercise of Options
26th Feb 20077:00 amPRNKey Development Milestone
21st Dec 200612:20 pmRNSResult of EGM
19th Dec 20067:02 amRNSToumaz Wins Oracle Award
5th Dec 20065:18 pmRNSNotice of EGM
22nd Nov 20065:41 pmRNSExercise of Options
3rd Nov 200611:55 amRNSExercise of Options
26th Oct 20064:09 pmRNSExercise of Options
13th Oct 20067:00 amPRNToumaz Debuts New Sensium(TM) Module
10th Oct 20063:58 pmRNSDirector/PDMR Shareholding
7th Sep 20065:12 pmPRNResult of AGM
7th Sep 20067:00 amPRNAppointment of CEO
6th Sep 20067:00 amPRNAGM Statement
23rd Aug 20067:00 amPRNStrategic Investment
18th Aug 20064:01 pmRNSHolding(s) in Company
3rd Jul 20067:00 amPRNDirectorate Change
30th Jun 20067:02 amRNSInterim Results
28th Apr 20067:00 amPRNFinal Results
21st Apr 20067:00 amPRNToumaz Appoints New CEO
13th Feb 200611:23 amRNSHolding(s) in Company
23rd Dec 20057:00 amPRNUpdate
11th Nov 20051:40 pmRNSHolding(s) in Company
9th Nov 20056:08 pmRNSHolding(s) in Company
7th Nov 200510:36 amRNSHolding(s) in Company
2nd Nov 20052:49 pmPRNResult of EGM
19th Oct 20051:35 pmRNSSchedule 1 - Nanoscience Inc
10th Oct 20056:00 amPRNAcquisition and Fundraising
10th Oct 20056:00 amPRNAcquisition and Fundraising
10th Oct 20056:00 amPRNAcquisition and Fundraising
21st Sep 20052:22 pmPRNInterim Results
31st Aug 200510:56 amPRNStrategic Investment
9th Jun 200510:00 amRNSRe Investment
3rd May 200512:17 pmRNSAppointment of Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.